Yoda Therapeutics Inc.
Update：2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
Neurology
Pipeline
Utilizing Yoda’s proprietary AI-based drug screening platform, we engage in the exploration and development of promising and beneficial products to address unmet medical needs, instilling new hope in patients.YA-101 Multiple System Atro
Pipeline
Utilizing Yoda’s proprietary AI-based drug screening platform, we engage in the exploration and development of promising and beneficial products to address unmet medical needs, instilling new hope in patients.YA-101 Multiple System Atro
Founded Year
2022
Unified Business No.
89116715
Status
Active
Number of Employees
0
Total Paid-in
Capital
773,881,600 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Yoda Pharmaceuticals Inc. was founded in 2019 through a collaboration of researchers from National Taiwan University, National Yang Ming Chiao Tung University, and the National Health Research Institutes, along with psychiatric physicians in practice. Inc
